Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
9/30/2025 | $ 834.95M | $ 203.16M | $ 0 | -24.33% |
6/30/2025 | $ 1.01B | $ 247.77M | $ 0 | -24.59% |
3/31/2025 | $ 705.94M | $ 485.52M | $ 0 | -68.78% |
12/31/2024 | $ 1.48B | $ 485.67M | $ 0 | -32.72% |
9/30/2024 | $ 1.67B | $ 285.15M | $ 0 | -17.04% |
6/30/2024 | $ 1.42B | $ 241.09M | $ 0 | -16.99% |
3/31/2024 | $ 771.18M | $ 3.36M | $ 0 | -0.44% |
12/31/2023 | $ 481.61M | $ 3.22M | $ 0 | -0.67% |
9/30/2023 | $ 302.18M | $ 3.08M | $ 0 | -1.02% |
6/30/2023 | $ 485.86M | $ 116.78M | $ 0 | -24.04% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for NURIX THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 219.11M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 1.55B ]
(=) Payout Yield [ -14.1% ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |